These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27743484)

  • 41. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
    Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Raised 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Iqbal S; Khan AH
    J Coll Physicians Surg Pak; 2013 May; 23(5):373-4. PubMed ID: 23673184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia.
    Rosenfield RL
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2993; author reply 2993. PubMed ID: 12050289
    [No Abstract]   [Full Text] [Related]  

  • 45. Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.
    Tsai WH; Wong CH; Dai SH; Tsai CH; Zeng YH
    Front Endocrinol (Lausanne); 2020; 11():526287. PubMed ID: 33117272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.
    Faurschou S; Mouritsen A; Johannsen TH; Hougaard DM; Cohen A; Duno M; Juul A; Main KM
    Acta Paediatr; 2015 Feb; 104(2):e57-62. PubMed ID: 25346389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 125I radioimmunoassay for 17 alpha-hydroxyprogesterone in plasma, for diagnosing and managing congenital adrenal hyperplasia.
    Yeo KH; Whitau WJ
    Clin Chem; 1985 Mar; 31(3):454-6. PubMed ID: 3971567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
    J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC; Elias LL
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3 alpha-Androstanediol glucuronide in premature and normal pubarche.
    Riddick LM; Garibaldi LR; Wang ME; Senne AR; Klimah PE; Clark AT; Levine LS; Oberfield SE; Pang SY
    J Clin Endocrinol Metab; 1991 Jan; 72(1):46-50. PubMed ID: 1846006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
    Sahlander F; Bensing S; Falhammar H
    Front Endocrinol (Lausanne); 2022; 13():1017303. PubMed ID: 36545328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
    Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
    Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR; Kelnar CJ; Wallace AM
    J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS; Ng ML; Wu LL; Khalid BA
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LC-MS/MS improves screening towards 21-hydroxylase deficiency.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Wysłouch-Cieszyńska A; Małunowicz EM; Bartoszewicz Z; Kondracka A; Jaźwiec R; Pawłowska E; Szcześniak M; Dadlez M; Bednarczuk T
    Gynecol Endocrinol; 2015 Apr; 31(4):296-300. PubMed ID: 25539143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.
    Ueland GÅ; Methlie P; Øksnes M; Thordarson HB; Sagen J; Kellmann R; Mellgren G; Ræder M; Dahlqvist P; Dahl SR; Thorsby PM; Løvås K; Husebye ES
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1696-1703. PubMed ID: 29452421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.